Reporting owner · CIK 0002023538
Nemec Sarah
Visual SEC Form 4 history across 1 companies, 6 transactions and 2 filings.
SV, FPSenior VP, Finance and PAOBolt Biotherapeutics, Inc.
Open-market mix
40%buys
Open-market buy performance
90-day forward return on this insider's open-market purchases
For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.
- Window follows the rest of the summary (all-history or last 3 months).
- Only buys with a resolved price context are counted.
- Includes both positive and negative outcomes; gains and losses net out at the per-buy level.
Monthly open-market activity
Reported purchase and sale transaction counts
Buys Sells
Net value flow
Buys minus sells
Dec 25
$575.9
Jan 26
$0
Jun 26
$2K
Sep 26
−$26.1K
Transaction texture
Ownership and ticket size
Average P/S size$5.7K
Median P/S size$3.2K
Direct6
Indirect0
Sep 18, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
Latest transaction
sale at Bolt Biotherapeutics, Inc. on Sep 18, 2026 valued at $13,195.
Review SEC filingAssociated companies
Visual map of known reporting history
Latest insider transactions
Form 4 filings from available history. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #227044 | BOLT | Nemec Sarah | SVFP | sale | 4.07k | -$1.31M | S | 09/21 | 09/18 |
| #227043 | BOLT | Nemec Sarah | SVFP | sale | 2.92k | -$969k | S | 09/21 | 09/17 |
| #227042 | BOLT | Nemec Sarah | SVFP | sale | 843 | -$318k | S | 09/21 | 09/16 |
| #227041 | BOLT | Nemec Sarah | SVFP | buy | 509 | $197k | P | 09/21 | 06/05 |
| #46485 | BOLT | Nemec Sarah | SVFP | grant | 8.00k | $0 | A | 02/04 | 01/28 |
| #46484 | BOLT | Nemec Sarah | SVFP | buy | 125 | $57.5k | P | 02/04 | 12/05/2025 |
Nemec Sarah Insider Activity FAQ
SEC Form 4 context
Who is Nemec Sarah?
Nemec Sarah is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002023538.
Which companies has Nemec Sarah reported transactions for?
Bolt Biotherapeutics, Inc.
When was Nemec Sarah's latest insider buy?
buy at Bolt Biotherapeutics, Inc. on Jun 05, 2026 valued at $1,973.
When was Nemec Sarah's latest insider sale?
sale at Bolt Biotherapeutics, Inc. on Sep 18, 2026 valued at $13,195.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.